Document is current
Any future updates will be listed below
-
Authors
Shang, Lihua
Hattori, Masaya
Fleming, Gini
Jaskowiak, Nora
Hedeker, Donald
Olopade, Olufunmilayo I.
Huo, Dezheng http://orcid.org/0000-0002-4041-1678
-
Funding
Funding for this research was provided by:
National Institutes of Health/National Cancer Institute (P20 CA233307, P20 CA233307)
Breast Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 27 August 2020
Accepted: 20 January 2021
First Online: 4 February 2021
Ethics approval and consent to participate
: The study has been approved by the institutional review board of the University of Chicago (protocol number 16352A). All participants gave their written informed consent to participate with the possibility to withdraw from the study at any time.
: Not applicable
: O.I. Olopade is an equity stock holder of CancerIQ and Tempus. Other authors declare no conflicts of interest.
